Ryan J. Watts - 20 Aug 2024 Form 4 Insider Report for Denali Therapeutics Inc. (DNLI)

Role
President and CEO, Director
Signature
/s/ Tyler Nielsen, by power of attorney
Issuer symbol
DNLI
Transactions as of
20 Aug 2024
Transactions value $
-$53,765
Form type
4
Filing time
22 Aug 2024, 16:16:23 UTC
Previous filing
29 Mar 2024
Next filing
22 Oct 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DNLI Common Stock Sale -$53,765 -2,260 -0.95% $23.79 235,807 20 Aug 2024 Direct F1, F2
holding DNLI Common Stock 2,202,604 20 Aug 2024 See footnote F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested restricted stock units.
F2 Includes 197,200 Unvested RSUs.
F3 The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee.